メニューにジャンプコンテンツにジャンプ

トップページ > 診療科・部門 > 診療科(外科系) > 泌尿器科 > 研究実績・活動実績 > 2017年度発表論文等一覧

2017年度発表論文等一覧

原著論文-英文

  1. Akiyama Y, Niimi A, Nomiya A, Yamada Y, Nakagawa T, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients.
    Neurourol Urodyn. 2018 Jan 9. doi: 10.1002/nau.23467.
  2. Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J, Taguchi S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
    World J Urol. 2017 Nov 28. doi: 10.1007/s00345-017-2141-2.
  3. Hara T, Fujimoto H, Kondo T, Shinohara N, Obara W, Kimura G, Kume H, Nonomura N, Hongo F, Sugiyama T, Kanayama HO, Takahashi M, Fukumori T, Eto M; Cancer Registration Committee of the Japanese Urological Association.
    Active heavy cigarette smoking is associated with poor survival in Japanese patients with advanced renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association.
    Jpn J Clin Oncol. 2017 Dec 1;47(12):1162-1169. doi: 10.1093/jjco/hyx129.
  4. Akiyama Y, Maeda D, Morikawa T, Niimi A, Nomiya A, Yamada Y, Igawa Y, Goto A, Fukayama M, Homma Y.
    Digital quantitative analysis of mast cell infiltration in interstitial cystitis.
    Neurourol Urodyn. 2017 Oct 24. doi: 10.1002/nau.23365.
  5. Niimi A, Igawa Y, Aizawa N, Honma T, Nomiya A, Akiyama Y, Kamei J, Fujimura T, Fukuhara H, Homma Y.
    Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.
    Neurourol Urodyn. 2017 Oct 19. doi: 10.1002/nau.23431.
  6. Takayama KI, Suzuki T, Fujimura T, Yamada Y, Takahashi S, Homma Y, Suzuki Y, Inoue S.
    Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF.
    Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):10461-10466. doi: 10.1073/pnas.1706076114. Epub 2017 Sep 11.
  7. Aizawa N, Ichihara K, Fukuhara H, Fujimura T, Andersson KE, Homma Y, Igawa Y.
    Characteristics of the mechanosensitive bladder afferent activities in relation with microcontractions in male rats with bladder outlet obstruction.
    Sci Rep. 2017 Aug 9;7(1):7646. doi: 10.1038/s41598-017-07898-y.
  8. Manley BJ, Zabor EC, Casuscelli J, Tennenbaum DM, Redzematovic A, Becerra MF, Benfante N, Sato Y, Morikawa T, Kume H, Fukayama M, Homma Y, Ogawa S, Arcila ME, Voss MH, Feldman DR, Coleman JA, Reuter VE, Motzer RJ, Russo P, Hsieh JJ, Hakimi AA.
    Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.
    Eur Urol Focus. 2016 Jul 16. pii: S2405-4569(16)30094-3. doi: 10.1016/j.euf.2016.06.015.
  9. Yamada Y, Fujimura T, Fukuhara H, Sugihara T, Nakagawa T, Kume H, Igawa Y, Homma Y.
    Predictors of Early Continence after Robot-assisted Radical Prostatectomy.
    Low Urin Tract Symptoms. 2017 Jul 11. doi: 10.1111/luts.12181.
  10. Yamada Y, Fujimura T, Fukuhara H, Sugihara T, Miyazaki H, Nakagawa T, Kume H, Igawa Y, Homma Y.
    Overactive bladder is a negative predictor of achieving continence after robot-assisted radical prostatectomy.
    Int J Urol. 2017 Oct;24(10):749-756. doi: 10.1111/iju.13411. Epub 2017 Jul 11.
  11. Nakagawa T, Taguchi S, Kanatani A, Kawai T, Ikeda M, Urakami S, Matsumoto A, Komemushi Y, Miyakawa J, Yamada D, Suzuki M, Enomoto Y, Nishimatsu H, Kondo Y, Nagase Y, Hirano Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?
    Ann Surg Oncol. 2017 Sep;24(9):2794-2800. doi: 10.1245/s10434-017-5970-8. Epub 2017 Jul 7.
  12. Fujimura T, Fukuhara H, Taguchi S, Yamada Y, Sugihara T, Nakagawa T, Niimi A, Kume H, Igawa Y, Homma Y.
    Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy.
    BMC Cancer. 2017 Jun 29;17(1):454. doi: 10.1186/s12885-017-3439-6.
  13. Gong X, Siprashvili Z, Eminaga O, Shen Z, Sato Y, Kume H, Homma Y, Ogawa S, Khavari PA, Pollack JR, Brooks JD.
    Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.
    Oncotarget. 2017 Mar 21;8(12):18657-18669. doi: 10.18632/oncotarget.15703.
  14. Sugihara T, Yasunaga H, Matsui H, Nagao G, Ishikawa A, Fujimura T, Fukuhara H, Fushimi K, Ohori M, Homma Y.
    Accessibility to surgical robot technology and prostate-cancer patient behavior for prostatectomy.
    Jpn J Clin Oncol. 2017 Jul 1;47(7):647-651. doi: 10.1093/jjco/hyx052.
  15. Nakagawa T, Komemushi Y, Kawai T, Otsuka M, Miyakawa J, Uemura Y, Kanatani A, Taguchi S, Naito A, Suzuki M, Nishimatsu H, Hirano Y, Tanaka Y, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    World J Urol. 2017 Oct;35(10):1569-1575. doi: 10.1007/s00345-017-2032-6. Epub 2017 Apr 10.
  16. Sugiyama R, Aizawa N, Ito H, Fujimura T, Suzuki M, Nakagawa T, Fukuhara H, Kume H, Homma Y, Igawa Y.
    Synergic Suppressive Effect of Silodosin and Imidafenacin on Non-Voiding Bladder Contractions in Male Rats with Subacute Bladder Outlet Obstruction.
    Low Urin Tract Symptoms. 2017 May;9(2):94-101. doi: 10.1111/luts.12109. Epub 2015 Jul 27.
  17. Yamada Y, Fujimura T, Fukuhara H, Sugihara T, Takemura K, Kakutani S, Suzuki M, Nakagawa T, Kume H, Igawa Y, Homma Y.
    Incidence and risk factors of inguinal hernia after robot-assisted radical prostatectomy.
    World J Surg Oncol. 2017 Mar 16;15(1):61. doi: 10.1186/s12957-017-1126-3.
  18. Taguchi S, Buti S, Fukuhara H, Otsuka M, Bersanelli M, Morikawa T, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Igawa Y, Homma Y.
    Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?
    PLoS One. 2017 Feb 27;12(2):e0172341. doi: 10.1371/journal.pone.0172341. eCollection 2017.
  19. Kamei J, Yagihara Y, Kume H, Horiuchi T, Sato T, Nakagawa T, Fujimura T, Fukuhara H, Moriya K, Homma Y.
    Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
    Int J Urol. 2017 Apr;24(4):295-300. doi: 10.1111/iju.13308. Epub 2017 Feb 21.
  20. Aizawa N, Ito H, Sugiyama R, Fujimura T, Fukuhara H, Kume H, Homma Y, Igawa Y.
    Effects of Sildenafil, a Phosphodiesterase Type 5 Inhibitor, on the Primary Single Afferent Activity of the Rat Bladder.
    Low Urin Tract Symptoms. 2017 Jan;9(1):57-61. doi: 10.1111/luts.12095. Epub 2015 Mar 19.
  21. Nakagawa T, Taguchi S, Uemura Y, Kanatani A, Ikeda M, Matsumoto A, Yoshida K, Kawai T, Nagata M, Yamada D, Komemushi Y, Suzuki M, Enomoto Y, Nishimatsu H, Ishikawa A, Nagase Y, Kondo Y, Tanaka Y, Okaneya T, Hirano Y, Shinohara M, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder.
    Urol Oncol. 2017 Jul;35(7):457.e15-457.e21. doi: 10.1016/j.urolonc.2016.12.010. Epub 2017 Jan 16.
  22. Tsuda Y, Nakagawa T, Shinoda Y, Kanatani A, Kawai T, Taguchi S, Yamada Y, Sawada R, Kume H, Homma Y, Tanaka S, Kawano H.
    Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.
    Int J Clin Oncol. 2017 Jun;22(3):548-553. doi: 10.1007/s10147-016-1075-9. Epub 2017 Jan 2.
  23. Misawa A, Takayama KI, Fujimura T, Homma Y, Suzuki Y, Inoue S.
    Androgen-induced lncRNA POTEF-AS1 regulates apoptosis-related pathway to facilitate cell survival in prostate cancer cells.
    Cancer Sci. 2017 Mar;108(3):373-379. doi: 10.1111/cas.13151.

原著論文-和文

口頭・ポスター発表-国際学会・研究会

口頭・ポスター発表-国内学会・研究会

著書・総説

その他